ReviewJournal of community genetics2026
Advancing genomic medicine in Nigeria: research progress, clinical translation and policy priorities.
Review in Journal of community genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundGenomic Medicine involves the comprehensive analysis of an individual's complete DNA set, the genome, to gain insights into the relationship between genes and how they influence diseases and individual responses to treatment modalities. It has created a solid foundation for advancements in precision medicine and understanding complex biological processes. One of the most groundbreaking achievements is the Human Genome Project (HGP), which was launched in October 1990, to generate a complete sequence of the human genome and identify all the genes present in it.
objectiveThis narrative review aims to assess the genomic medicine landscape in Nigeria and examine its prospects in the Nigerian context, including its potential public health impacts.
resultsNigeria has developed an expanding genomic research ecosystem involving pathogen surveillance, human genetics, cancer genomics, pharmacogenomics, bioinformatics and capacity-building initiatives. However, translation into routine clinical and public-health applications remains constrained by limited infrastructure, sustainable domestic financing, specialised workforce capacity, data governance systems, and access to genomic services. International collaborations have substantially contributed to infrastructure and capacity development, but long-term sustainability requires stronger domestic investment and institutionalisation.
conclusionDue to the numerous potentials of genomic medicine in the management of diseases such as sickle cell disease, stroke, nephrotic syndrome, infectious diseases, cancer, etc., it is important that more funding is provided for research in this field. Favourable policies should also be formulated and implemented to increase genomics training opportunities, improve research participation, and promote local and international collaborations.
Indexed as
Identifiers
42853488What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.